全文获取类型
收费全文 | 32177篇 |
免费 | 2441篇 |
国内免费 | 51篇 |
专业分类
耳鼻咽喉 | 230篇 |
儿科学 | 1130篇 |
妇产科学 | 873篇 |
基础医学 | 4207篇 |
口腔科学 | 344篇 |
临床医学 | 4872篇 |
内科学 | 5911篇 |
皮肤病学 | 396篇 |
神经病学 | 3060篇 |
特种医学 | 874篇 |
外科学 | 2910篇 |
综合类 | 422篇 |
一般理论 | 74篇 |
预防医学 | 4454篇 |
眼科学 | 499篇 |
药学 | 1959篇 |
1篇 | |
中国医学 | 28篇 |
肿瘤学 | 2425篇 |
出版年
2023年 | 123篇 |
2022年 | 201篇 |
2021年 | 514篇 |
2020年 | 350篇 |
2019年 | 554篇 |
2018年 | 662篇 |
2017年 | 520篇 |
2016年 | 551篇 |
2015年 | 596篇 |
2014年 | 927篇 |
2013年 | 1447篇 |
2012年 | 2124篇 |
2011年 | 2193篇 |
2010年 | 1212篇 |
2009年 | 1046篇 |
2008年 | 2059篇 |
2007年 | 2182篇 |
2006年 | 2139篇 |
2005年 | 2155篇 |
2004年 | 2058篇 |
2003年 | 1923篇 |
2002年 | 1773篇 |
2001年 | 410篇 |
2000年 | 353篇 |
1999年 | 442篇 |
1998年 | 432篇 |
1997年 | 314篇 |
1996年 | 312篇 |
1995年 | 285篇 |
1994年 | 263篇 |
1993年 | 228篇 |
1992年 | 295篇 |
1991年 | 277篇 |
1990年 | 256篇 |
1989年 | 263篇 |
1988年 | 221篇 |
1987年 | 218篇 |
1986年 | 219篇 |
1985年 | 226篇 |
1984年 | 177篇 |
1983年 | 210篇 |
1982年 | 188篇 |
1981年 | 172篇 |
1980年 | 178篇 |
1979年 | 139篇 |
1978年 | 117篇 |
1977年 | 125篇 |
1976年 | 118篇 |
1975年 | 112篇 |
1974年 | 112篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
Annette Jackson Cynthia McSherry Kim Butters Michael Diko P.Stephen Almond Arthur J Matas Nancy L Reinsmoen 《Human immunology》1997,55(2):148-153
Our previous studies have shown that the in vitro assay of donor antigen-specific hyporeactivity is a useful marker for identifying solid organ transplant recipients (kidney, lung and heart) at low risk for immunologic complications (i.e., late acute rejection episodes and chronic rejection). Donor antigen-specific hyporeactivity is defined as a significantly decreased post- vs. pretransplant proliferative response to donor antigens while response to third-party controls remains unchanged. We analyzed whether exposure to the same HLA-DR antigen pretransplant via random blood transfusion and posttransplant via the transplanted organ influenced the development of hyporeactivity. Thirty previously nontransfused recipients, each receiving two 150 ml pretransplant random blood transfusions, were assessed for hyporeactivity at 1 year posttransplant. Of the 12 recipients with pretransplant exposure to kidney HLA-DR via transfusions, 6 (50%) developed hyporesponsiveness; in contrast, of the 18 recipients who were not preexposed, only 3 (15%) exhibited this form of immunomodulation. Of interest, 2 of the 3 hyporesponsive recipients who were not preexposed, received units containing HLA-DR antigens previously shown to share crossreactive epitopes with the kidney HLA-DR. In conclusion, these results suggest a increased incidence in the development of hyporeactivity in patients receiving pretransplant transfusions which share an HLA-DR antigen with the transplanted kidney. 相似文献
72.
73.
N Bellamy W W Buchanan J M Esdaile A G Fam W F Kean J M Thompson G A Wells J Campbell 《The Journal of rheumatology》1991,18(11):1716-1722
Defining the minimum clinically important difference or delta to be detected in a clinical trial depends on a number of factors including the research hypothesis, patient characteristics, the nature of the intervention and the trial design. In 2 previous studies, we have developed standardized procedures for conducting outcome measurement based on current Food and Drug Administration and European League Against Rheumatism guidelines for clinical trials in ankylosing spondylitis, and thereafter, determined the standard deviation for these outcome measures. In the final component of this series of studies, we have employed a Delphi technique to establish estimates for delta, and calculated the sample size requirements under 2 different conditions of Type I and Type II error probabilities. 相似文献
74.
75.
Nancy P. Caraway Gregg A. Staerkel Christina V. Fanning Datla G. Varma Raphael E. Pollock 《Diagnostic cytopathology》1994,11(3):255-261
The gross and microscopic appearances of aspirates from ten intramuscular myxomas are reported. The specimens were obtained from seven women and three men, ages 43 to 75, who had tumors involving the muscles of the thigh (7), upper arm (2), and forearm (1). Magnetic resonance (MR) imaging performed in six of the ten cases revealed well-defined, sharply demarcated tumors exhibiting low signal intensity relative to muscle on the T1-weighted images. The tumors were hyperintense to muscle on T2-weighted images. All aspirated tissues were clear, tenacious, and viscous. Smears contained few spindled and histiocytoid cells in an abundant mucoid background. Spindle cells demonstrated long cytoplasmic processes that in areas intertwined to form fibrillar tangles. Nuclei were oval to spindled with fine chromatin and inconspicuous nucleoli. Capillaries were sparse with simple (nonplexiform) branching. The differential diagnosis of myxoid lesions of the extremities includes benign entities such as myxoid schwannoma and neurofibroma, mesenchymal repair, and ganglion cyst, as well as malignant neoplasms such as myxoid liposarcoma, fibrosarcoma, malignant fibrous histiocytoma, and extraskeletal chondrosarcoma. The findings of this study revealed that, although the cytologic features were suggestive of intramuscular myxoma, a definitive diagnosis was often difficult, owing to scant cellularity and lack of distinctive cytologic features. The MR imaging findings may be utilized as an adjunct to the cytologic features to more confidently suggest a diagnosis of intramuscular myxoma. Diagn Cytopathol 1994;11:255–261. © 1994 Wiley-Liss, Inc. 相似文献
76.
77.
J Wells Askew Todd D Miller David O Hodge Raymond J Gibbons 《Journal of the American College of Cardiology》2007,50(11):1080-1085
OBJECTIVES: We sought to determine if screening for coronary artery disease (CAD) with stress single-photon emission computed tomography (SPECT) is of value in patients with atrial fibrillation (AF) who do not have symptoms of chest pain or dyspnea. BACKGROUND: Although noninvasive stress testing is often done to screen for CAD in asymptomatic patients with AF and is considered to be appropriate in selected patients, its potential utility has not been demonstrated. METHODS: A retrospective study was conducted of 374 asymptomatic patients with AF referred for the detection of CAD. Mean follow-up was 5.7 +/- 3.8 years. The study group was compared with a control group of 374 asymptomatic age and gender-matched patients without AF. RESULTS: The mean summed stress score (SSS) was not significantly different between AF patients and control subjects (3.6 +/- 5.3 vs. 3.5 +/- 5.9; p = 0.35). Compared with controls, asymptomatic AF patients had similar rates of abnormal SPECT studies (51.6% vs. 48.4%; p = 0.38) and high-risk studies (14.4% vs. 14.4%; p = 1.0). The SSS was a significant predictor of outcome in both AF patients and control subjects. However, total mortality was significantly greater in AF patients (5-year overall mortality 27% vs. 18%, 10-year overall mortality 47% vs. 40%; p < 0.001), and this difference persisted (p = 0.01) after adjusting for multiple clinical variables and the SSS. CONCLUSIONS: Screening for CAD using stress SPECT in asymptomatic AF patients has a yield similar to age- and gender-matched control patients without AF. Although SSS predicts mortality in patients with and without AF, patients with AF have increased total mortality independent of the findings on stress SPECT. These results suggest that factors other than obstructive CAD are responsible for the increased mortality in AF. 相似文献
78.
J D Wells 《Journal of medical entomology》1991,28(3):471-473
Chrysomya megacephala (F.), an Old World calliphorid of considerable public health importance, was first discovered in Brazil in 1977 and is now widely distributed in Latin America. Reports that this species has become established in southern California, and the collection of a specimen in Texas, suggest that C. megacephala may be expanding its range rapidly in North America. The biology and worldwide spread of this pest are reviewed to alert entomologists and public health workers to this growing threat. 相似文献
79.
80.
Nancy L York 《Dimensions of critical care nursing》2004,23(2):84-88
Families' needs of patients being resuscitated in critical care areas are frequently not a high priority for the healthcare team. However, recent research suggests family member presence during life-saving efforts may help families cope with the devastating outcomes of unsuccessful resuscitation. This article provides the rationale and process for implementing a family presence option during resuscitation. 相似文献